Washington University researchers at Siteman Cancer Center received a $10.8 million grant through the National Cancer Institute’s Specialized Programs of Research Excellence (SPORE). Led by principal…

The University of Kansas Medical Center is partnering with the University of Wisconsin Center for Tobacco Research and Intervention to determine what treatments work best to help Black people quit sm…

Virginia Commonwealth University has been awarded a five-year, $9 million grant from the National Cancer Institute to establish a Cancer Control Equity Research Center. This initiative aims to enhanc…

Fred Hutch Cancer Center researchers developing immunotherapies using engineered adaptive immune system cells have received over $4 million in research grants from the Washington Research Foundation.…

Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the Department of Defense Congressionally Directed Medical Research Programs to deve…

Julie In, PhD, has received a five-year, $1.9 million grant from the National Institute of Environmental Health Sciences. She will study the molecular changes in intestinal epithelium cells when expo…

Ross and Mary Whipple pledged $1.5 million to the University of Arkansas for Medical Sciences (UAMS), supporting rural cancer care, patient services, and orthopedics. The gifts include $1 million to …

A project led by Vanderbilt University Medical Center aims to use artificial intelligence to generate antibody therapies against any antigen target of interest. VUMC has been awarded up to $30 millio…

Physician-scientist Theodore Scott Nowicki, MD, PhD, has been awarded a $4.5 million R37 MERIT Award to help improve the effectiveness of cellular therapies for solid tumors. Dr. Nowicki and his team…

A researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has received a $1.9 million grant from the National Institute of Environmental H…

A University of Arizona Cancer Center researcher has received a $1.2 million grant from the American Cancer Society to evaluate potential links between the neighborhood environment and cancer risk. R…

W. Kimryn Rathmell, MD, PhD, has accepted the role of CEO of OSUCCC – The James. Pending approval by the university board of trustees, she will start on May 27. Dr. Rathmell served as the 17th direct…

Steven Leach, MD, director of the Dartmouth Cancer Center (DCC) has announced his intention to step down as director in early 2026. He has led the DCC through two successful National Cancer Institute…

Thomas A. Sellers, PhD, MPH, has stepped down as director of the OHSU Knight Cancer Institute after a year in the position. Lisa Coussens, PhD, FAACR, FAIO, has been named interim director. Dr. Selle…

RWJBarnabas Health and Rutgers Cancer Institute have appointed H. John Pounardjian, MBA, as chief financial and administrative officer and deputy director for administration and planning. Pounardjian…

Samir Parekh, MD, a hematologist and researcher, has been named director of the Center of Excellence for Multiple Myeloma at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.…

Shivaani Kummar, MD, FACP, has been appointed as interim Knight Cancer Chief Executive of the OHSU Knight Cancer Institute. She fills the role previously held by Brian Druker, MD. Dr. Kummar will als…

Patricia Thompson, PhD, has been appointed to serve the University of Arizona Cancer Center as associate director of strategy. She will join the center’s Scientific Leadership Council and will work c…

Roland Dunbrack, PhD, professor in the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, has been appointed co-leader of the program alongside its current leader, Edn…

Sulma Mohammed, DVM, PhD, a cancer biology and health disparities researcher, has been named co-leader of the UF Health Cancer Center’s Cancer Control and Population Sciences research program. She wi…

Jennifer Woyach, MD, a blood cancer doctor and researcher who has been with Ohio State for more than 12 years, has been named director of the Division of Hematology at OSUCCC – The James.

Meric Mericliler, MD, has joined the George Washington (GW) University Cancer Center and the GW Medical Faculty Associates as a hematologist-oncologist specializing in benign hematology.

This news has been reposted under the correct source.

Karen E. Knudsen, MBA, PhD, has announced her transition from CEO of the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network. An interim CEO is expec…

The Sandra and Edward Meyer Cancer Center of Weill Cornell Medicine and NewYork-Presbyterian Hospital has appointed a trio of physicians and researchers to oversee the center’s first Office of Divers…

The University of Michigan Rogel Cancer Center has named Veera Baladandayuthapani, PhD, as associate director for quantitative data sciences, a role that recognizes the increasing significance of dat…

Joshua Mammen, MD, PhD, has small-town roots and wants to ensure that Nebraskans know that the Fred & Pamela Buffett Cancer Center is the cancer center for all of Nebraska. Dr. Mammen, who became…

John M. Ashton, PhD, MBA, associate professor in the Department of Biomedical Genetics, has been promoted from assistant director to associate director of shared resources at Wilmot Cancer Institute.…

Lisa Harlan-Williams, PhD, associate professor of Cell Biology and Physiology, has been appointed associate director for education at The University of Kansas Cancer Center. She will oversee cancer-r…

Ravi B. Parikh, MD, MPP, FACP, a physician-scientist and expert in health care artificial intelligence and machine learning, joined Winship Cancer Institute of Emory University on September 1. Dr. Pa…

Sabrina Samudio-Ruiz, PhD, assumed the role of shared resources associate director on September 16. She will oversee the development of all eight of the center's shared resources, set the direction f…

Devin Koestler, PhD, professor and associate director of research operations in the Department of Biostatistics & Data Science, has been appointed assistant director for shared resources at The U…

Doris Benbrook, PhD, has been named associate director for translational research at OU Health Stephenson Cancer Center. In the role, Dr. Benbrook will oversee planning and initiatives designed to fa…

Carla Strom, MLA, has been appointed administrative director for community outreach and engagement at Vanderbilt-Ingram Cancer Center. She was recruited from Atrium Health Wake Forest Baptist Compreh…

Georgios Skiniotis, PhD, has been appointed to develop and lead the newly created Center of Excellence for Structural Cell Biology. The center will advance understanding of cell biology from the atom…

The University of Michigan Rogel Cancer Center has named Kyle Cuneo, MD, its new associate director for clinical research. In addition, a new position of assistant director for clinical research will…

Masonic Cancer Center (MCC) has announced that Jeffrey Miller, MD, (pictured) will serve as the center’s interim director. MCC extends its deep appreciation to Douglas Yee, MD, for his leadership ove…

Huntsman Cancer Institute (HCI) at the University of Utah announces the appointment of Deanna Kepka, PhD, MPH, investigator at HCI and professor in the College of Nursing, as the inaugural leader of …

Marci Lee Nilsen, PhD, RN, CHPN, FAAN, is the new co-lead of UPMC Hillman Cancer Center's Biobehavioral Cancer Control program. Dr. Nilsen is also director of the Head and Neck Cancer Survivorship Pr…

The GW Cancer Center announces the addition of Prashanth Ashok Kumar, MD, to its hematologist-oncologist team. With a background in thoracic oncology, Dr. Ashok Kumar brings a wealth of expertise in …

Breast cancer surgeon Tari A. King, MD, FACS, FSSO, FASCO, has been appointed chief surgical officer for the cancer service line at Winship Cancer Institute and Emory Healthcare. She will also serve …

Moffitt Cancer Center and its wholly owned subsidiary SPEROS FL, a 775-acre global innovation campus, has announced Josh Carpenter, D.Phil., as the president of Speros and Moffitt’s chief integration…

Tracy Smith, PhD, (pictured) has joined Ashish Deshmukh, PhD, as a co-leader of the Cancer Prevention and Control Research Program at MUSC Hollings Cancer Center. Dr. Smith's research focuses on redu…

Jenny Freedman, PhD, member of the Duke Cancer Institute Center for Prostate and Urologic Cancers, explains how a natural gene-splicing process can run amok, producing prostate cancer cells. Dr. Free…

Training the next generation of cancer researchers is essential for the cancer research enterprise. However, training programs and methods to evaluate their effectiveness vary greatly across the USA …

A University of Arizona Health Sciences-led study found that patients are more likely to get colonoscopies following abnormal stool test results if patient navigators assist them through the process.…

Histone lysine demethylases, or KDMs, were first documented in 2004 in a groundbreaking study that led to new understandings about the genetic mechanisms of cancer and other diseases. Now, researcher…

In a study co-led by the University of Maryland School of Medicine, researchers have identified a "master regulator" gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinica…

Scientists at UC San Diego—in collaboration with researchers at Stanford University, Harvard Medical School, and the University of British Columbia—have created a comprehensive, interactive map of U2…

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hop…

A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, has identified a novel oncometabolite that accumulates in tumors and impairs…

A team of UK Markey Cancer Center researchers have found the mechanism that grants prostate cancer resistance to enzalutamide. Prostate cancer patients who don’t respond to usual hormonal treatments …

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to a preclinical study led by Roswell Park Comprehensive Cancer Center.

A recent study sheds new light on the prevalence of positive lung cancer screenings in patients following a low-dose chest CT (LDCT) for lung cancer screening. The research compared clinical screenin…

UF Health Cancer Center researchers have discovered a crucial mechanism by which a common gene mutation leads to resistance against platinum-based chemotherapy in non-small cell lung cancer.

UK Markey Cancer Center researchers have identified a mechanism by which a gut hormone contributes to fatty liver disease, offering potential new targets for treating the common condition. The study …

In the mid-2000s, when a team of researchers led by Dennis Slamon, MD, PhD, and Richard Finn, MD, began investigating a compound developed by Pfizer called PD-0332991, few thought it would fly. Today…

An editorial argues that patients with resectable non-small cell lung cancer who achieve a complete pathological response after neoadjuvant chemoimmunotherapy should still receive adjuvant immunother…

Researchers at Baylor College of Medicine, Texas Children’s Hospital, the Hospital for Sick Children in Toronto, and collaborating institutions have discovered a novel line of communication between m…

Looking beyond DNA, Fred Hutch and Memorial Sloan Kettering Cancer Center scientists found that common RNA splicing-factor mutations in myelodysplastic syndrome and acute myeloid leukemia cells creat…

Stanford Medicine scientists are using artificial intelligence to better capture how healthy cells surrounding tumors influence cancer cell behavior and how those interactions can inform treatments.

In the 1960s, astronauts returned from microgravity with decreased bone density. This decrease revealed that bones must undergo constant stress to grow and maintain themselves. Survivors of childhood…

The latest UCSF research has reexamined immunotherapy clinical trial data on bladder and skin cancer and found that "cold" tumors, ones that haven’t yet been infiltrated by immune cells, are just as …

Nearly half of Americans who smoke use menthol cigarettes, which are harder to quit. A new University of Michigan study will test the best way to help menthol cigarette smokers break that habit. The …

Researchers at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute and Memorial Sloan Kettering Cancer Center in New York have found a link bet…

A nationwide team led by researchers at Baylor College of Medicine, Texas Children’s Hospital, and UPMC Children's Hospital of Pittsburgh has proposed a major revision to how Langerhans cell histiocy…

In 2021, a provision in the 21st Century Cures act took effect which required that all medical test results be released to a patient’s electronic medical record as soon as they become available. As a…

Two new studies led by Washington University physician-scientist Stephen T. Oh, MD, PhD, at Siteman Cancer Center have identified a possible way to block the progression of several forms of blood can…

A new study led by UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.…

Investigators from Baylor College of Medicine, Texas Children’s Cancer and Hematology Center, the Center for Cell and Gene Therapy at Baylor, Houston Methodist Hospital, and Texas Children’s Hospital…

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses small, targeted amounts of steam to kill cancer cells is a safe and effective…

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new st…

Women who develop bacterial vaginosis (BV) often later acquire chlamydia. Now, researchers at Albert Einstein College of Medicine, Roswell Park Comprehensive Cancer Center, and the Icahn School of Me…

Compared with other forms of breast cancer, triple-negative breast cancer (TNBC) is more likely to have spread at the time of diagnosis and is more likely to recur, largely because it becomes resista…

A non-opioid investigational drug with promising pre-clinical results in treating neuropathic pain has passed an important hurdle after the study’s safety review committee reviewed the data from init…

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center, have developed a new tool that could change the way cancer patients are treated…

UK Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant cancers by targeting a specific protein modification.

A new study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificia…

Mount Sinai scientists have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma. The research tested a combination of treatments that could help patients live longe…

A new artificial intelligence (AI) tool developed by Stanford cancer faculty members combines data from medical images with text to predict cancer prognoses and treatment responses.

A first-of-its-kind new cancer test has been developed at the University of Michigan. MyHPVscore is a highly accurate blood test that can detect human papilloma virus-related head and neck cancer by …

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and—due to innovations in manufacturing—could make future cellular immunotherapies less expensive and more accessible to pati…

Read More

A new study provides insights into how medulloblastoma can arise as the cerebellum develops. Researchers at Baylor College of Medicine, Texas Children’s Cancer Center, University of Toronto, St. Jude…

Read More

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified key metabolic mechanisms that squamous cell skin cancers use to resist treatment,…

A nurse-led initiative at the Vanderbilt Breast Center has set up a system so that women identified at high risk for breast cancer have greater opportunities for recommended follow-up screenings and …

Using a new workflow that integrates spatial transcriptomics and machine learning for imaging analysis and integration with single-cell datasets, researchers at the Johns Hopkins Kimmel Cancer Center…

Scientists at Huntsman Cancer Institute at the University of Utah have made a significant breakthrough in predicting the prognosis of triple-negative breast cancer (TNBC). Their research has led to t…

Every year, more than 22,000 patients in the U.S. undergo a potentially lifesaving blood stem cell transplant. But historically, some patients with blood cancers have been less likely than others to …

An international panel of top cancer doctors led by UVA Health experts has identified indicators that reflect the effectiveness of coordinated team care to improve outcomes for patients with brain me…

Staging of patients with early pancreatic cancer is inaccurate as much as 80 percent of the time, according to a new Cedars-Sinai Cancer study. The finding underscores the urgent need for advancement…

Scientists from St. Jude Children’s Research Hospital, Seattle Children’s, and the Children’s Oncology Group have identified novel genetic variations that influence relapse risk in children with stan…

Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patie…

Results from a clinical trial by the ECOG-ACRIN Cancer Research Group show a striking improvement for patients who received chemotherapy before surgery to remove advanced squamous cell-type cancer of…

Researchers have published a report on pathogenic germline variants in DNA repair genes and how these inherited genetic variants might impact both the risk of developing multiple myeloma and patient …

An international clinical trial, called NATALEE, has led to the U.S. Food and Drug Administration approving ribociclib in combination with hormonal therapy for the adjuvant treatment of HR-positive, …

Results from a new UK Markey Cancer Center study show that molecular tumor boards can play an important role in identifying potential inherited cancer risks, leading to better patient care. Specifica…

People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a …

Two recent scientific papers about optimal treatment of older patients with cancer not only improves clinical care but also demonstrates Wilmot Cancer Institute’s international leadership in this gro…